Key Takeaways
- On July 10, 2026, Broadcom’s Chief Legal Officer Mark Brazeal offloaded 25,000 shares worth approximately $10.03 million at $401.33 per share average.
- This transaction occurred outside a Rule 10b5-1 trading plan, which typically governs pre-arranged executive stock sales.
- Following the sale, Brazeal retains ownership of 194,989 shares, with 123,750 being restricted stock units.
- Shares of AVGO finished Tuesday’s session at $389.11, gaining 1.32%, and have climbed 40% year-over-year.
- Analyst consensus points to Strong Buy with a $513.29 average target price, suggesting approximately 31% potential gains.
Mark David Brazeal, who serves as Broadcom’s Chief Legal and Corporate Affairs Officer, divested 25,000 AVGO shares on July 10, 2026, generating roughly $10.03 million in proceeds. The transaction occurred within a price range of $401.22 to $401.47, averaging $401.33 per share.
This divestment constituted approximately 11% of Brazeal’s stake prior to the transaction. His remaining position includes 194,989 shares, with 123,750 of those being restricted stock units.
Broadcom shares finished Tuesday’s trading at $389.11, posting a 1.32% gain. Over the trailing twelve months, the stock has delivered approximately 40% returns.
Notably, the Form 4 disclosure revealed this transaction wasn’t executed under a Rule 10b5-1 trading arrangement. Such plans allow corporate insiders to establish predetermined selling schedules, effectively eliminating concerns about trading based on material non-public information. While the absence of such a plan warrants attention, it doesn’t necessarily indicate red flags.
Executive stock sales occur for various legitimate purposes: portfolio rebalancing, tax obligations, estate planning, or personal liquidity requirements. A single transaction by Broadcom’s top legal executive shouldn’t fundamentally alter the investment thesis.
Street Sentiment Remains Positive
Wall Street analysts show no signs of concern. Broadcom holds a Strong Buy consensus rating derived from 26 analyst opinions — comprising 23 Buy recommendations and 3 Hold ratings. The consensus price target stands at $513.29, representing roughly 31% appreciation potential from present levels.
According to InvestingPro’s valuation models, AVGO appears undervalued at current trading levels, with Fair Value calculations indicating additional upside opportunity.
CLSA recently adjusted its Broadcom price objective to $600 while maintaining its Outperform stance, highlighting the company’s custom ASIC development pipeline as a key growth driver.
Jefferies reaffirmed its Buy recommendation, emphasizing robust demand projections for artificial intelligence semiconductors. Similarly, Evercore ISI maintained its Outperform rating on Apple, partially based on its strengthened collaboration with Broadcom.
Latest Corporate Developments
Apple and Broadcom revealed an enhanced multi-year collaboration focused on engineering and manufacturing proprietary silicon chips and wireless technology components. This agreement is projected to surpass $30 billion in value and yield over 15 billion domestically manufactured chips.
In another significant move, Broadcom partnered with OpenAI to introduce the Jalapeño AI inference processor, developed alongside Celestica. This specialized chip aims to enhance large language model inference performance.
Regarding capital structure, Broadcom disclosed pricing details for a $2.5 billion tender offer targeting senior notes with maturity dates spanning 2030 through 2038.
Should multiple Broadcom executives begin liquidating substantial positions at comparable valuations, that would constitute a more troubling indicator for shareholders. Currently, the fundamental investment narrative — including favorable analyst perspectives, strategic partnerships, and AI semiconductor tailwinds — remains firmly in place.
The Street’s $513.29 average price target suggests approximately 31% appreciation potential from Tuesday’s closing price of $389.11.





